Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
3 Ergebnisse für "concord" unter Roche Glycart AG
Elecsys® β-Amyloid(1-42) CSF II
... al. (2018). CSF biomarkers of Alzheimer’s disease concord with amyloid-β PET and predict clinical ... Dementia. JAMA 321(13), 1286-1294. Hansson, O. et al. (2018). CSF biomarkers of Alzheimer’s disease concord ...
Elecsys® Phospho-Tau (181P) CSF
... ), 1286-1294. Hansson, O. et al. (2018). CSF biomarkers of Alzheimer’s disease concord with amyloid-β PET ... disease concord with amyloid-β PET and predict clinical progression: A study of fully automated ...
